Argos Therapeutics, Inc. , a biopharmaceutical company focused on the development and commercialization of fully personalized immunotherapies for the treatment of cancer and infectious diseases using its Arcelis technology platform, today reported financial results for the fourth quarter and year ended December 31, 2013 and provided an update on ... (more)
http://ift.tt/1jT3VHm
http://ift.tt/1jT3VHm
No comments:
Post a Comment